North Fourth Asset Management’s GoodRx Holdings GDRX Stock Holding History

North Fourth Asset Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-30,000	Closed	-$1.67M	–	140
2020 Q3	$1.67M	Buy	+30,000	New	+$1.59M	0.41%	53

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

North Fourth Asset Management's GDRX Position: Q4 2020 in Review

North Fourth Asset Management sold out of GoodRx Holdings (GDRX) in Q4 2020, closing a stake of 30,000 shares — an estimated $1.67M sold.

North Fourth Asset Management first reported a position in GDRX in Q3 2020 and held it in 1 quarter. The position peaked at $1.67M in Q3 2020. 192 funds tracked by Wall St. Rank hold GDRX as of Q4 2020.

North Fourth Asset Management reported no remaining GoodRx Holdings position as of Q4 2020 after selling out during the quarter.
North Fourth Asset Management sold 30,000 GoodRx Holdings shares in Q4 2020, an estimated $1.67M.
North Fourth Asset Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 1 quarter.
North Fourth Asset Management's GoodRx Holdings position peaked at $1.67M in Q3 2020.
192 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2020.

Based on North Fourth Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.